Journal article
Efficacy and Tolerability of Gefapixant for Treatment of Refractory or Unexplained Chronic Cough
Abstract
Importance: Gefapixant represents an emerging therapy for patients with refractory or unexplained chronic cough.
Objective: To evaluate the efficacy and tolerability of gefapixant for the treatment of adults with refractory or unexplained chronic cough.
Authors
Kum E; Patel M; Diab N; Wahab M; Zeraatkar D; Chu DK; O’Byrne PM; Guyatt GH; Satia I
Journal
JAMA: The Journal of the American Medical Association, Vol. 330, No. 14, pp. 1359–1369
Publisher
American Medical Association (AMA)
Publication Date
October 10, 2023
DOI
10.1001/jama.2023.18035
ISSN
0098-7484